Dollar Tree (NASDAQ: DLTR) is still growing, but its short-term earnings outlook is worsening. Dollar Tree is seeing strong customer traffic, even as shoppers become more cautious in their spending patterns. Customer traffic gains were strong, hitting 6% in the Dollar Tree brand and 4% at Family Dollar.
The man is accused of leaving the baby with severe burns requiring multiple surgeries.
Monday's Apple iPhone 16 unveiling is key for AI and a reeling stock market. Palantir and Dell will be joining the S&P 500. Elon Musk's xAI has discussed sharing Tesla FSD revenue.
Republican attempts to land early blows ahead of Tuesday’s encounter on the debate stage
TORONTO, Ontario, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that Titan management will host a webcast Q&A session on Thursday, September 19, 2024 at 5:00 pm ET in connection with filing and mailing of the management information circular, which was announced by press release issued on September 6, 2024. Titan will provide prepared remarks followed by a Q&A session. Paul Cataford, Interim President and CEO and Chien Huang, Chief Financial Offi
OVERLAND PARK, Kan., September 09, 2024--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced it will release its fourth quarter and full year 2024 financial results before market open on Friday, September 13, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (September 13, 2024) at 8:30 am ET to discuss t
HOUSTON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (“Itafos” or the “Company”) announced today that it has entered into an amendment of its existing credit facilities with a syndicate of lenders led by RBC Capital Markets, pursuant to which the Company will refinance its existing $85 million loan (with $35.4 million outstanding) and its $35 million letter of credit facility (together, the “Existing Term Loan Agreement”) for a new commitment of $100 million and a $30 million le
ATLANTA, September 09, 2024--Papa John’s International, Inc. (NASDAQ: PZZA) ("Papa Johns®") announced the appointment of Kevin Vasconi to Chief Digital and Technology Officer, effective today. Mr. Vasconi brings proven enterprise technology leadership to the company. He most recently served as Chief Information Officer for The Wendy’s Company, where he led their transformation and tripled its ecommerce business in three years through a consumer-centric approach, leveraging technology to build lo
Rapid advancements in AI and automation are propelling the Robot Controller, Integrator, and Software Market to quadruple by 2034. Strong growth, especially in Asia-Pacific, is driven by Industry 4.0 and the increasing need for precision and efficiency across industries.NEWARK, Del, Sept. 09, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the robot controller, integrator, and software market is projected to be valued at USD 6.3 Billion in 2024. Over the next decade, this fig
Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that data from the Phase 1 study of CK-4021586 (CK-586) were presented in a poster session at the American College of Clinical Pharmacology (ACCP) Annual Meeting in Bethesda, MD. The study met its primary and secondary objectives to assess the safety, tolerabili
Governments Worldwide Increasing Deployment of Fixed Wing Drones to Combat Potential Terrorist Threats.Rockville, MD, Sept. 09, 2024 (GLOBE NEWSWIRE) -- According to a recently updated research report compiled by Fact.MR, the global fixed wing drone market is expected to reach a size of US$ 8.3 billion in 2024 and further expand at a high-value CAGR of 17.2% from 2024 to 2034. Integration of advanced sensors and laser technology have made fixed wing drones ideal for different types of inspection
CALGARY, Alberta, Sept. 09, 2024 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) today announced the setting of the distribution record date of Sept. 25, 2024 for the previously announced spinoff of TC Energy’s Liquids Pipelines business into South Bow Corporation (South Bow), by way of a plan of arrangement (the Arrangement). Pursuant to the Arrangement, TC Energy shareholders will retain their interest in TC Energy and receive a pro rata int
VICTORIA, British Columbia, September 09, 2024--Vecima announces its return to IBC 2024 in Amsterdam, highlighting multiple video industry innovations, including its MediaScale Open CDN solution.
JERUSALEM, September 09, 2024--Mobileye (Nasdaq: MBLY) has chosen to end the internal development of next-generation frequency modulated continuous wave (FMCW) lidars for use in autonomous and highly automated driving systems.
PRT3789, a novel, highly-selective SMARCA2 degrader in patients with advanced solid tumors with a SMARCA4 mutation oral session presentation: September 13, 2024, 4:00 PM CEST (10:00 AM EST) Prelude will host an investor webcast on September 13, 2024, 6:00 PM CEST, (12:00 PM EST) WILMINGTON, Del., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication of an abstr
NASHVILLE, Tenn., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences, today provided an updated investor presentation ahead of its participation in the Bank of America Securities 2024 Global Real Estate Conference. The presentation can be found on the Investor Relations section of the Company’s website u
Adds SaaS-native, AI-powered, document-centric collaboration platform to its robust enterprise software portfolio and continues to execute its Total Growth StrategyBURLINGTON, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider of AI-powered infrastructure software, today announced it has entered into a definitive agreement to acquire ShareFile, a business unit of Cloud Software Group, Inc., providing SaaS-native, AI-powered, document-centric collaboration, fo
MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company’s President and CEO, Paul Lévesque will be presenting at two investor conferences in September. Members of the Theratechnologies management team will also be available for one-on-one meetings throughout the conferences. H.C. Wainwri
Esports Powerhouse Diversifies into Game Development Industry Veteran Allen Sui to Lead New Venture SHENZHEN, China, Sept. 09, 2024 (GLOBE NEWSWIRE) -- NIP Group Inc. (NASDAQ: NIPG) (the “Company” or “NIP Group”), a leading digital entertainment company, today announced that it has established a dedicated game publishing division. This strategic move marks a significant expansion of NIP Group's digital entertainment ecosystem and leverages the Company's esports expertise to tap into the booming
DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of VASCEPA®/VAZKEPA (icosapent ethyl) in patients with diabetes and high cardiovascular risk and the anti-Lp(a) oxidation mechanistic effects of eicosapentaenoic acid (EPA) will be presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting September 9 – 13, 2024 in Madrid, Sp
Patient screening to be initiated imminently; first subject expected to be randomized into the study in OctoberNEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of naturally derived psilocybin-based therapeutics, today announced that the first site initiation visit has been successfully completed at the first Australian clinical trial site for the Company’s Phase IIb study of nature derived (non-synthetic) psilocyb
Yahoo Finance